<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190625044003N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-09-12</date_registration>
      <primary_sponsor>Iran National Science Foundation</primary_sponsor>
      <public_title>The efficiency of articulated ankle-foot orthosis and rocker sole shoe on walking biomechanics in stroke patients</public_title>
      <acronym></acronym>
      <scientific_title>The efficiency of articulated ankle-foot orthosis with first and second rockers mechanism and rocker sole shoe on walking biomechanics in patients with hemiplegic stroke: Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/40392</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Since the sampling method in the present study is consecutive. It means that researcher gets present at the patients' referral site (Dr. Jawad Mowafaghian Research Center for Intelligent NeuroRehabilitation Technologies) from the beginning of the study, and patients who are eligible to participate in the study are identified and then, invited to participate in the study. Therefore, randomization is occurred consecutively. It should be noted that only one rehabilitation center is sampled in this study. In this study, simple randomization method is used and randomization unit is individual. In this way, participants with the odd number assigned to them (By order of referral) are included in the intervention group, and participants with the even number assigned to them are included in the control group. The allocation concealment is that Participants are unaware of the allocation of groups (intervention and control group), Blinding description: Participants (patients) are unaware of the allocation of groups (intervention group and control group). That is, participants are unaware of which group, intervention group, and which group is the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>cerebrovascular accident (stroke).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: ankle foot orthosis (AFO) with plantar flexion resistance and 2 kind of shoes (standard shoe and rocker shoe). Intervention 2: Control group: Intervention group: ankle foot orthosis (AFO) with plantar flexion resistance and 2 kind of shoes (standard shoe and rocker shoe).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All above will be published in the article

When:
After the article publication

To whom:
After the article publication, people can access

Conditions:
Other researchers and therapists in the rehabilitation and medical field can use this use the data of this study after the article publication

Where to obtain:
After the article publication, people can find the article by searching in internet and access the data

How to obtain:
After the article publication, people can find the article by searching in internet and access the data

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Aliyeh Daryabor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Address: Kodakyar Ave., Daneshjo Blvd.,Evin,Post code: : 1985713871</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۹۸۵۷۱۳۸۳۴</zip>
        <telephone>+98 21 2218 0010</telephone>
        <email>r_daryabor@yahoo.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Aliyeh Daryabor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kodakyar Ave., Daneshjo Blvd.,Evin,University of Social Welfare and Rehabilitation Science</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۹۸۵۷۱۳۸۳۴</zip>
        <telephone>+98 21 2218 0010</telephone>
        <email>r_daryabor@yahoo.com</email>
        <affiliation>University of social welfare and rehabilitation sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 40 to 68
Stroke patients should have plantarflexors spasticity at least 2 according to the modified Ashworth scale (MAS)
A minimum of 6 months poststroke
No involvement in the contralateral limb
Able to walk independently
Patients should have the passive ability to dorsiflex ankle joint</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>68 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The presence of hammered toes,
Fixed contraction in the ankle, hip and knee joints,
Having a history of cardiovascular and pulmonary disease
Patients with knee hyperflexion
Very poor balance based on TUG test</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46.3*</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Brain stem stroke syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: ankle foot orthosis (AFO) with plantar flexion resistance and 2 kind of shoes (standard shoe and rocker shoe)</i_keyword>
      <i_keyword>Control group: Intervention group: ankle foot orthosis (AFO) with plantar flexion resistance and 2 kind of shoes (standard shoe and rocker shoe)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Temporal-spatial parameters (walking speed, step length, stride length, cadence). Timepoint: In this study, after fabrication of orthoses for patients, the subjects use the made orthosis for adapting in daily living for 2 weeks. Then, patients refer to gait biomechanics laboratory, and gait parameters are measure in two condition, without orthosis and with orthosis. Method of measurement: Three-dimensional movement capture system (vicon).</prim_outcome>
      <prim_outcome>Walking Kinematic (sagittal joints angles of ankle, knee and hip, and pelvic 3-dimensional angles in pelvis and thorax). Timepoint: In this study, after fabrication of orthoses for patients, the subjects use the made orthosis for adapting in daily living for 2 weeks. Then, patients refer to gait biomechanics laboratory, and walking Kinematic are measure in two condition, without orthosis and with orthosis. Method of measurement: Three-dimensional movement capture system (vicon).</prim_outcome>
      <prim_outcome>Walking Kinetic (sagittal joints moments of ankle, knee and hip, anterior-posterior ground reaction force). Timepoint: In this study, after fabrication of orthoses for patients, the subjects use the made orthosis for adapting in daily living for 2 weeks. Then, patients refer to gait biomechanics laboratory, and walking Kinetics are measure in two condition, without orthosis and with orthosis. Method of measurement: Kistler forceplate.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Fatigue during walking with orthoses. Timepoint: In this study, after fabrication of orthoses for patients, the subjects use the made orthosis for adapting in daily living for 2 weeks. Then, patients refer to gait biomechanics laboratory, and fatigue variable are measure in two condition, without orthosis and with orthosis by the questionnaire. Method of measurement: Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran National Science Foundation</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-12-02</approval_date>
        <contact_name>Ethics committee of University of Social Welfare and Rehabilitation Science</contact_name>
        <contact_address>Address: kodakyar Ave., daneshjo Blvd.,Evin,Post code: : 1985713871 tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
